Tsukuba, Japan

Ayumi Takemura

USPTO Granted Patents = 2 


Average Co-Inventor Count = 10.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ayumi Takemura: Innovator in Orexin Receptor Antagonism

Introduction

Ayumi Takemura is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that target orexin receptors. With a total of 2 patents to her name, her work is paving the way for advancements in the treatment of sleep disorders.

Latest Patents

Takemura's latest patents include innovative methods and compounds useful in the synthesis of orexin-2 receptor antagonists. The first patent provides compounds and methods that are essential for preparing orexin-2 receptor antagonists. The second patent describes a cyclopropane compound that exhibits orexin receptor antagonism, showing potential for treating sleep disorders such as insomnia. This compound is represented by a specific formula and includes various substituents that enhance its pharmacological properties.

Career Highlights

Ayumi Takemura is currently employed at Eisai R&D Management Co., Ltd., where she continues to focus on her research in pharmacology. Her work is instrumental in developing new therapeutic options for patients suffering from sleep-related issues.

Collaborations

Throughout her career, Takemura has collaborated with notable colleagues, including Taro Terauchi and Yu Yoshida. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Ayumi Takemura's contributions to the field of pharmacology, particularly in the area of orexin receptor antagonism, highlight her role as a leading inventor. Her patents represent significant advancements in the treatment of sleep disorders, showcasing her dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…